{"DataElement":{"publicId":"4308162","version":"1","preferredName":"Reduced Pigmentation Disease or Disorder Present Type","preferredDefinition":"A description of the pigmentary dilution disorder.","longName":"4308157v1.0:4308159v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"4308157","version":"1","preferredName":"Reduced Pigmentation Disease or Disorder Present","preferredDefinition":"Made less in size or amount or degree._Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Being or existing in a specified place or at the specified time.","longName":"4308155v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"4308155","version":"1","preferredName":"Reduced Pigmentation Disease or Disorder","preferredDefinition":"Made less in size or amount or degree.:Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C25640:C38005:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pigmentation","conceptCode":"C38005","definition":"Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E0A14-6A46-74D0-E040-BB89AD433449","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"ONEDATA","dateModified":"2014-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E0A14-6A54-74D0-E040-BB89AD433449","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"KUMMEROA","dateModified":"2020-01-30","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4308159","version":"1","preferredName":"Reduced Pigmentation Disease or Disorder Type","preferredDefinition":"Made less in size or amount or degree._Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Something distinguishable as an identifiable class based on common qualities.","longName":"4308159v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other pigmentary dilution disorder","valueDescription":"Other Reduced Pigmentation Disease or Disorder","ValueMeaning":{"publicId":"4308160","version":"1","preferredName":"Other Reduced Pigmentation Disease or Disorder","longName":"4308160","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Made less in size or amount or degree.: Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pigmentation","conceptCode":"C38005","definition":"Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E0A14-6B05-74D0-E040-BB89AD433449","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F94E0A14-6B1E-74D0-E040-BB89AD433449","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"ONEDATA","dateModified":"2014-05-13","deletedIndicator":"No"},{"value":"Hermansky-Pudlak syndrome type 2","valueDescription":"Hermansky-Pudlak Syndrome","ValueMeaning":{"publicId":"3211144","version":"1","preferredName":"Hermansky-Pudlak Syndrome","longName":"3211144","preferredDefinition":"A group of autosomal recessive inherited disorders characterized by albinism, bleeding tendency, and lung disorders such as pulmonary fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hermansky-Pudlak Syndrome","conceptCode":"C37261","definition":"A group of autosomal recessive inherited disorders characterized by albinism, bleeding tendency, and lung disorders such as pulmonary fibrosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-D418-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F94E0A14-6B28-74D0-E040-BB89AD433449","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"ONEDATA","dateModified":"2014-05-13","deletedIndicator":"No"},{"value":"Griscelli syndrome type 2","valueDescription":"Griscelli Syndrome Type 2","ValueMeaning":{"publicId":"3940912","version":"1","preferredName":"Griscelli Syndrome Type 2","longName":"3940912","preferredDefinition":"A rare, autosomal recessive genetic syndrome caused by mutations in the RAB27A gene.  It is characterized by hypopigmentation of the skin, hair and eyes, recurrent infections, neutropenia, and immune system abnormalities.  Patients are prone to develop hemophagocytic lymphohistiocytosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Griscelli Syndrome Type 2","conceptCode":"C111814","definition":"A rare, autosomal recessive genetic syndrome caused by mutations in the RAB27A gene.  It is characterized by hypopigmentation of the skin, hair and eyes, recurrent infections, neutropenia, and immune system abnormalities.  Patients are prone to develop hemophagocytic lymphohistiocytosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA08B251-5CA6-ED4B-E040-BB89AD4371A4","latestVersionIndicator":"Yes","beginDate":"2013-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F94E0A14-6B32-74D0-E040-BB89AD433449","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"ONEDATA","dateModified":"2014-05-13","deletedIndicator":"No"},{"value":"Chediak-Higashi syndrome","valueDescription":"Chediak-Higashi Syndrome","ValueMeaning":{"publicId":"4308161","version":"1","preferredName":"Chediak-Higashi Syndrome","longName":"4308161","preferredDefinition":"A rare autosomal recessive immunodeficiency disorder characterized by abnormal intracellular protein transport. Chediak-Higashi syndrome (CHS) is characterized by immune deficiency; partial oculocutaneous albinism; a bleeding disorder due to deficient platelet dense bodies; neutropenia; neutrophils with impaired chemotaxis and bactericidal activity; recurrent infection; and abnormal natural killer (NK) cell function. CHS may be associated with hepatosplenomegaly, lymphadenopathy, anemia, thrombocytopenia, roentgenologic changes in bones, lungs and heart, and skin and psychomotor abnormalities; it is often fatal in childhood as a result of infection or an accelerated lymphoma-like phase. CHS occurs in mink, cattle, and mice, as well as man.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chediak-Higashi Syndrome","conceptCode":"C2941","definition":"A rare autosomal recessive immunodeficiency disorder characterized by abnormal intracellular protein transport. Chediak-Higashi syndrome (CHS) is characterized by immune deficiency; partial oculocutaneous albinism; a bleeding disorder due to deficient platelet dense bodies; neutropenia; neutrophils with impaired chemotaxis and bactericidal activity; recurrent infection; and abnormal natural killer (NK) cell function. CHS may be associated with hepatosplenomegaly, lymphadenopathy, anemia, thrombocytopenia, roentgenologic changes in bones, lungs and heart, and skin and psychomotor abnormalities; it is often fatal in childhood as a result of infection or an accelerated lymphoma-like phase. CHS occurs in mink, cattle, and mice, as well as man.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E0A14-6B3C-74D0-E040-BB89AD433449","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F94E0A14-6B55-74D0-E040-BB89AD433449","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"ONEDATA","dateModified":"2014-05-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4308158","version":"1","preferredName":"Reduced Pigmentation Disease or Disorder Type","preferredDefinition":"Made less in size or amount or degree.:Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Something distinguishable as an identifiable class based on common qualities.","longName":"C25640:C38005:C2991:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pigmentation","conceptCode":"C38005","definition":"Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E0A14-6AD9-74D0-E040-BB89AD433449","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"ONEDATA","dateModified":"2014-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E0A14-6AEA-74D0-E040-BB89AD433449","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"KUMMEROA","dateModified":"2021-01-06","changeDescription":". 2021-1-6 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"PDDpre_assess_diag_pdd_dis_name","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the reduced pigmentat","type":"Preferred Question Text","description":"What is the reduced pigmentation disease or disorder type?","url":null,"context":"NHLBI"},{"name":"What is the diagnosis?","type":"Alternate Question Text","description":"What is the diagnosis?","url":null,"context":"NHLBI"},{"name":"What is the diagnosis?","type":"Application Standard Question Text","description":"What is the diagnosis?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E57ED-FBCC-35BE-E040-BB89AD430D0C","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"KUMMEROA","dateModified":"2021-01-06","changeDescription":". 2021-1-6 ak OK to release per WZ. System generated def displayed as alt def. AK 11/17/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}